SEC Form 4 · accession 0000919574-17-005589
Insight Molecular Diagnostics Inc. · IMDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
BROADWOOD PARTNERS, L.P.
10% Owner
BROADWOOD CAPITAL INC
10% Owner
Neal C Bradsher
10% Owner
Period of report
Jul 21, 2017
Accepted (ET)
Jul 25, 2017 · 5:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001642380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, no par valueF1 | Jul 21, 2017 | X | 540,000 | $3.25 | A | 3,596,680 | D | |
| Common Stock, no par valueF2 | Jul 21, 2017 | X | 0 | $3.25 | A | 3,596,680 | I | Footnote |
| Common Stock, no par valueF6 | holding | — | — | — | 3,145 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant to Purchase Common StockF4,F1,F3 | $3.25 | Jul 21, 2017 | X | 540,000 | D | — | Oct 17, 2021 | Common Stock | 540,000 | 573,461 | D |
| Warrant to Purchase Common StockF4,F2,F3 | $3.25 | Jul 21, 2017 | X | 0 | D | — | Oct 17, 2021 | Common Stock | 0 | 573,461 | I |
| Warrant to Purchase Common StockF5,F1,F3 | $3.25 | Jul 21, 2017 | J | 270,000 | A | — | Jul 21, 2022 | Common Stock | 270,000 | 270,000 | D |
| Warrant to Purchase Common StockF5,F2,F3 | $3.25 | Jul 21, 2017 | J | 0 | A | — | Jul 21, 2022 | Common Stock | 0 | 270,000 | I |
| Warrant to Purchase Common StockF1,F3 | $3.25 | holding | — | — | — | — | Feb 17, 2022 | Common Stock | 212,500 | 212,500 | D |
| Warrant to Purchase Common StockF2,F3 | $3.25 | holding | — | — | — | — | Feb 17, 2022 | Common Stock | 0 | 212,500 | I |
Explanation of responses
- F1These securities are owned by Broadwood Partners, L.P., which is a Reporting Person.
- F2The reported securities are directly owned by Broadwood Partners, L.P. and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners, L.P. and Neal C. Bradsher as President of Broadwood Capital, Inc. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- F3These warrants are currently exercisable.
- F4These warrants were purchased as part of a unit, with each unit consisting of one share and one warrant (each warrant entitles the holder to purchase one share), at a price of $3.25 per unit.
- F5In consideration for the early exercise by Broadwood Partners, L.P. of 540,000 warrants on July 21, 2017, Broadwood Partners, L.P. received from the Issuer one new warrant with an exercise price of $3.25 for every two warrants that it exercised.
- F6The securities are owned by Neal C. Bradsher, who is a Reporting Person.